Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Avax to begin pivotal trial with M-Vax in melanoma patients

July 31, 1998

MabThera now available for non-Hodgkin's lymphoma in the U.K.

July 23, 1998

FDA grants second orphan drug designation for ImmTher

July 20, 1998

Medarex begins clinical trials of Bispecific antibody for cancer

July 20, 1998

Phase II trial of Avicine in prostate cancer announced

July 17, 1998

AltaRex initiates second phase II trial of OvaRex

July 16, 1998

Theragyn phase III testing will begin in U.K.

July 13, 1998

Regressin holds promise for a wide range of cancers, new data indicates

July 13, 1998

IL-4 fusion toxin shows potent antitumor activity in murine model of KS

July 10, 1998

NeoPharm scales up IL13-PE38QQR manufacturing

July 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Capital remains selective in ‘barbell’ biotech market
BioWorld Asia
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...